Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 28 06 2022
revised: 17 11 2022
accepted: 19 11 2022
medline: 2 6 2023
pubmed: 9 12 2022
entrez: 8 12 2022
Statut: ppublish

Résumé

The blood-brain barrier ensures CNS homeostasis and protection from injury. Claudin-5 (CLDN5), an important component of tight junctions, is critical for the integrity of the blood-brain barrier. We have identified de novo heterozygous missense variants in CLDN5 in 15 unrelated patients who presented with a shared constellation of features including developmental delay, seizures (primarily infantile onset focal epilepsy), microcephaly and a recognizable pattern of pontine atrophy and brain calcifications. All variants clustered in one subregion/domain of the CLDN5 gene and the recurrent variants demonstrate genotype-phenotype correlations. We modelled both patient variants and loss of function alleles in the zebrafish to show that the variants analogous to those in patients probably result in a novel aberrant function in CLDN5. In total, human patient and zebrafish data provide parallel evidence that pathogenic sequence variants in CLDN5 cause a novel neurodevelopmental disorder involving disruption of the blood-brain barrier and impaired neuronal function.

Identifiants

pubmed: 36477332
pii: 6881740
doi: 10.1093/brain/awac461
doi:

Substances chimiques

Claudin-5 0
CLDN5 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2285-2297

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/2
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Ashish R Deshwar (AR)

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Cheryl Cytrynbaum (C)

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Harsha Murthy (H)

Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Jessica Zon (J)

Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

David Chitayat (D)

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

Jonathan Volpatti (J)

Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Ruth Newbury-Ecob (R)

Department of Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8EG, UK.

Sian Ellard (S)

Molecular Genetics, Royal Devon & Exeter NHS Foundation Trust, Exeter, EX2 5DW, UK.

Hana Lango Allen (HL)

MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, CB2 0SL, UK.

Emily P Yu (EP)

Zebrafish Genetics and Disease Models Core Facility, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Ramil Noche (R)

Zebrafish Genetics and Disease Models Core Facility, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Suzi Walker (S)

The Centre for Applied Genomics, Genetics, and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Stephen W Scherer (SW)

Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
The Centre for Applied Genomics, Genetics, and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Sonal Mahida (S)

Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, MA 02115, USA.

Christopher M Elitt (CM)

Fetal-Neonatal Neurology Program, Department of Neurology, Boston Children's Hospital, Boston, MA 02115, USA.
F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA.
Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.

Gaël Nicolas (G)

Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, UNIROUEN, INSERM U1245 and Rouen University Hospital, Normandie University, F 76000 Rouen, France.

Alice Goldenberg (A)

Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, UNIROUEN, INSERM U1245 and Rouen University Hospital, Normandie University, F 76000 Rouen, France.

Pascale Saugier-Veber (P)

Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, UNIROUEN, INSERM U1245 and Rouen University Hospital, Normandie University, F 76000 Rouen, France.

Francois Lecoquierre (F)

Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, UNIROUEN, INSERM U1245 and Rouen University Hospital, Normandie University, F 76000 Rouen, France.

Ivana Dabaj (I)

Department of Neonatology and Pediatric Intensive Care-Pediatric Neurology, Rouen University Hospital, and INSERM U1245, Normandie University, UNIROUEN, 76000 Rouen, France.

Hannah Meddaugh (H)

Department of Genetics, Children's Hospital of New Orleans, New Orleans, LA 70118, USA.

Michael Marble (M)

Department of Genetics, Children's Hospital of New Orleans, New Orleans, LA 70118, USA.
Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Kim M Keppler-Noreuil (KM)

Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53792, USA.

Lucy Drayson (L)

Pediatric Specialists of Virginia, Fairfax, VA 22031, USA.

Kristin W Barañano (KW)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MA 21287, USA.

Anna Chassevent (A)

Division of Neurogenetics, Kennedy Krieger Institute, Baltimore, MA 21205, USA.

Katie Agre (K)

Department of Clinical Genomics, Mayo Clinic, Rochester, NY 55905, USA.

Pascaline Létard (P)

Department of Clinical Genetics, Service de Génétique, CHU de Poitiers, CS 90577 - 86021 Poitiers Cedex, France.

Frederic Bilan (F)

Department of Clinical Genetics, Service de Génétique, CHU de Poitiers, CS 90577 - 86021 Poitiers Cedex, France.
EA3808 NEUVACOD, University of Poitiers, 86073 Poitiers, France.

Gwenaël Le Guyader (G)

Department of Clinical Genetics, Service de Génétique, CHU de Poitiers, CS 90577 - 86021 Poitiers Cedex, France.
EA3808 NEUVACOD, University of Poitiers, 86073 Poitiers, France.

Annie Laquerrière (A)

Department of Pathology, Normandy Centre for Genomic and Personalized Medicine, Normandie Univeristy, UNIROUEN, INSERM U1245 and Rouen University Hospital, F76000 Rouen, France.

Keri Ramsey (K)

Translational Genomics Research Institute, Center for Rare Childhood Disorders, Phoenix, AZ 85004, USA.

Lindsay Henderson (L)

GeneDx, Gaithersburg, MD 20877, USA.

Lauren Brady (L)

Department of Pediatrics, McMaster University, Hamilton, ON L8S 4K1, Canada.

Mark Tarnopolsky (M)

Department of Pediatrics, McMaster University, Hamilton, ON L8S 4K1, Canada.

Matthew Bainbridge (M)

Rady Children's Institute for Genomic Medicine, San Diego, CA 92123, USA.

Jennifer Friedman (J)

Rady Children's Institute for Genomic Medicine, San Diego, CA 92123, USA.
Department of Neurosciences, University of California San Diego, San Diego, CA 92093, USA.
Department of Pediatrics, University of California San Diego, San Diego, CA 92093, USA.

Yline Capri (Y)

Département de Génétique, Assistance Publique des Hôpitaux de Paris (AP-HP) Hôpital Robert Debré, 75019 Paris, France.

Larissa Athayde (L)

Mendelics Genomic Analysis, Sao Paulo CEP 02511-000, Brazil.

Fernando Kok (F)

Mendelics Genomic Analysis, Sao Paulo CEP 02511-000, Brazil.

Juliana Gurgel-Giannetti (J)

Department of Pediatrics, Federal University of Minas Gerais School of Medicine, Belo Horizonte - MG - CEP 31270-901, Brazil.

Luiza L P Ramos (LLP)

Mendelics Genomic Analysis, Sao Paulo CEP 02511-000, Brazil.

Susan Blaser (S)

Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

James J Dowling (JJ)

Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Division of Neurology, The Hospital for Sick Children, Toronto, ON M5G1X8, Canada.
Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

Rosanna Weksberg (R)

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Institutes of Medical Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH